- Open Access
Cigarette smoke-promoted acquisition of bacterial pathogens in the upper respiratory tract leads to enhanced inflammation in mice
© Voss et al.; licensee BioMed Central. 2015
- Received: 6 November 2014
- Accepted: 9 March 2015
- Published: 20 March 2015
Bacterial colonization and recurrent infections of the respiratory tract contribute to the progression of chronic obstructive pulmonary disease (COPD). There is evidence that exacerbations of COPD are provoked by new bacterial strains acquired from the environment. Using a murine model of colonization, we examined whether chronic exposure to cigarette smoke (CS) promotes nasopharyngeal colonization with typical lung pathogens and whether colonization is linked to inflammation in the respiratory tract.
C57BL/6 N mice were chronically exposed to CS. The upper airways of mice were colonized with nontypeable Haemophilus influenzae (NTHi) or Streptococcus pneumoniae. Bacterial colonization was determined in the upper respiratory tract and lung tissue. Inflammatory cells and cytokines were determined in lavage fluids. RT-PCR was performed for inflammatory mediators.
Chronic CS exposure resulted in significantly increased numbers of viable NTHi in the upper airways, whereas NTHi only marginally colonized air-exposed mice. Colonization with S. pneumoniae was enhanced in the upper respiratory tract of CS-exposed mice and was accompanied by increased translocation of S. pneumoniae into the lung. Bacterial colonization levels were associated with increased concentrations of inflammatory mediators and the number of immune cells in lavage fluids of the upper respiratory tract and the lung. Phagocytosis activity was reduced in whole blood granulocytes and monocytes of CS-exposed mice.
These findings demonstrate that exposure to CS impacts the ability of the host to control bacterial colonization of the upper airways, resulting in enhanced inflammation and susceptibility of the host to pathogens migrating into the lung.
- Cigarette smoke
- Bacterial colonization
Respiratory diseases associated with cigarette smoke (CS) are a leading cause of morbidity and mortality worldwide. The most prominent respiratory disease caused by CS is chronic obstructive pulmonary disease (COPD) and it is most likely that it will constitute the fourth most common cause of death by the year 2030 . A hallmark of COPD is chronic inflammation of the lung, leading to tissue destruction. The ongoing tissue destruction leads to emphysema and loss of pulmonary function [2,3].
Stable COPD patients are frequently colonized by bacterial pathogens, such as nontypeable H. influaenzae, Pseudomonas aeruginosa, and S. pneumoniae [2,4,5]. Moreover, recurrent infections of the respiratory tract and chronic bronchitis are common in COPD [2-5]. It is suggested that acute bacterial lung infections as well as chronic bacterial colonization of the lung contribute to the progression of COPD by amplifying inflammation which further promotes lung damage and impacts innate lung defence . In addition, pathogenic bacteria cause direct damage to the epithelial surfaces of the lung and thereby contribute to impaired mucociliary clearance, elevated mucus secretion and subsequent mucus retention, disrupted ciliary activity, and finally airflow obstruction [3,6,7].
There is evidence that exacerbations are provoked by the acquisition of new bacterial strains from the environment by the host [2,3]. It is hypothesized that newly-acquired bacterial pathogens trigger infections of the lung and evoke harmful inflammatory responses, contributing to clinical deterioration of the patient during exacerbation [2,3,8]. Among the most frequent bacterial pathogens isolated from patients suffering from exacerbation are H. influenzae (20–30% of patients) and S. pneumoniae (10–15% of patients) .
Several studies have shown that CS has an impact on the immune system of the respiratory tract, even in healthy individuals [9,10]. Thus, smoking and passive smoking are associated with disordered microbial communities of the upper airways, impairment of commensal airway flora, and an increased risk of bacterial infections in healthy individuals [4,11-14]. Brook and Goober demonstrated that the nasopharyngeal flora of smokers contains fewer aerobic and anaerobic organisms with interfering capabilities and more potential pathogens, such as H. influenzae and S. pneumoniae, compared with those of non-smokers . It is also suggested that smoking enhances colonization of the oral cavity with periodontal pathogens, affects the sub-gingival microflora in periodontitis, and is a risk factor for periodontal disease [15,16]. Moreover, cigarette smoking increases the risk of community-acquired pneumonia [17,18] and is a strong independent risk factor for invasive pneumococcal disease among immunocompetent, non-elderly adults . Exposure to passive smoke favors bacterial colonization and infection in infants [12-14,20]. Greenberg et al. reported that children of smoking parents have a significantly higher rate of S. pneumoniae carriage than children of non-smokers . Exposure to passive smoke also correlates with a significantly increased risk of infants developing infections of the lower respiratory tract in the first two years of life .
It was the aim of the present study to investigate whether chronic exposure to CS promotes nasopharyngeal colonization with the leading gram-positive and gram-negative bacterial lung pathogens H. influenzae and S. pneumoniae by combining a clinically relevant murine model of colonization of the upper respiratory tract with a model of chronic CS exposure . It was further investigated whether CS-promoted colonization of the upper-respiratory tract results in increased inflammation and bacterial translocation into the lung.
Bacterial strains and products
A patient isolate of H. influenzae (ATCC® 49247™) was grown overnight at 37°C and 5% CO2 on chocolate agar (Becton Dickinson, Germany). Bacteria were taken from the plate and re-suspended in 7 ml 1 × PBS to obtain an optical density of 1 at 600 nm. Bacteria were spun at 4000 rpm and 4°C for 10 minutes and re-suspended in 350 μl 1 × PBS for the infection. A type 6A clinical isolate of S. pneumoniae (a gift from Dr. Jeffrey Weiser, University of Pennsylvania) [22,23] was cultured in Todd Hewitt broth at 37°C. Mid-log-phase S. pneumoniae were washed with PBS and re-suspenended in 450 μl 1 × PBS.
CS exposure and nasopharyngeal colonization
All animal experiments were approved by the Landesamt für Soziales, Gesundheit und Verbraucherschutz of the State of Saarland following the national guidelines for animal treatment. Mice were maintained under a pathogen-free condition. 7 to 9 week-old female wild-type C57BL/6 N mice were exposed to a combination of sidestream and mainstream CS (3R4F, College of Agriculture, Reference Cigarette Program, University of Kentucky, Lexington, Kentucky, USA) in a TE-10 smoking machine (Teague Enterprises, Woodland, California, USA) for a total of 261 minutes/day, 5 days per week. The smoking time was 87 minutes with 40 minutes air exposure in between CS exposures, with 3 CS exposures/day. Mice were exposed to CS or air for 13 (3 months) or 30 weeks (7 months) as indicated in the figures. The CS concentration was 120 mg/m3 total suspended particles. 24 hours after the final CS exposure the upper airways of room air- and CS-exposed mice were colonized using an established model of nasopharyngeal colonization [22-24]. Mice were inoculated intranasally with 10 μl of mid-log phase NTHi (5.5 × 106 to 4.5 × 107 CFU) or S. pneumoniae 6A (1.5 × 107 to 2.5 × 107 CFU) applied atraumatically to the nares without anesthesia.
Lavage of the upper airways and bronchoalveolar lavage and phagocytosis
Lavage of the upper airways and bronchoalveolar lavage (BAL) were performed as described before [22,23]. Briefly, the animals were sacrificed and the trachea were cannulated. Lavage of the upper airways was performed with 300 μl of PBS. To obtain BAL fluids from the lung BAL was performed with 1 ml of PBS flushed three times into the lungs. Lavage fluids were plated in serial dilutions and CFUs were determined. Lavage fluids were centrifuged to obtain immune cells and supernatants. Cell numbers were determined. Inflammatory cells were differentiated on cytospins. Serum was obtained by cardiac puncture. Phagocytosis activity of whole blood monocytes and granulocytes obtained from mice exposed to air or CS for 3 months was determined using a flow cytometry-based assays (Phagotest, Orpegen Pharma, Germany), according to the instruction. Samples were analyzed in a FACS Calibur flow cytometer (Beckton Dickinson, Heidelberg, Germany). Gates (forward/side scatter) were set on granulocytes and monocytes. For determination of the phagocytosis activity in each sample the mean fluorescence intensity was calculated according to the instruction of the manufacturer (MFI).
Determination of cytokine concentrations and immunohistochemistry
Concentrations of inflammatory mediators were assessed by cytometric bead array (CBA) using a FACSCanto II (BD Bioscience, Germany). For immunohistochemistry of the upper respiratory tract, the heads of the mice were fixed in 4%-PBS-buffered formaldehyde and decalcified . Immunohistochemistry on paraffin sections was performed as described before, using anti-H. influenzae (abcam, USA) antibody [25,26].
Quantitative real-time PCR
Total RNA from the upper airways was isolated after flushing the upper airways to obtain cells . The upper airways were flushed with 300 μl RLT Lysis buffer (Qiagen, Germany). RNA was isolated and reverse transcription and real-time PCR were performed as described before . Primers were: mouse β-Actin: 5′-AGC CAT GTA CGT AGC CAT CC-3′ and 5′-CTC TCA GCT GTG GTG GTG AA-3′, mouse Lysozyme M: 5′-CTG GCT ACT ATG GAG TCA GC-3′and 5′-TTG ATC CCA CAG GCA TTC AC-3′, mouse MIP-2: 5′-AAG TTT GCC TTG ACC CTG AA-3′ and 5′-AGG CAC ATC AGG TAC GAT CC-3′, and mouse mBD-1: 5′-GGC TGC CAC CAC TAT GAA AAC TC-3′ and 5′-GAG ACA GAA TCC TCC ATG TTG AA-3′.
Values are displayed as mean ± SEM. The Mann–Whitney test was used to compare the groups. Results were considered statistically significant for p < 0.05. All statistical tests were performed using the software Prism (GraphPad Software, San Diego, CA, USA).
CS exposure promotes colonization of the upper airways with NTHi and S. pneumoniae
CS exposure leads to increased translocation of S. pneumoniae into the lung
We examined whether increased colonization of the upper airways correlated with enhanced bacterial numbers in the lung. To determine the number of viable bacteria in lung tissue, the lungs were dissected and the trachea was removed. CFUs were determined in lung homogenates. Viable NTHi were not detectable in the lung tissue of either CS- or air-exposed mice. Only small numbers of viable S. pneumoniae were determined in the lung tissue of both air- and CS-exposed mice (Figure 2B). The numbers of S. pneumoniae in the lung tissue were, however, enhanced in mice which had been chronically exposed to CS prior to bacterial colonization. Significantly increased numbers of viable S. pneumoniae were determined in the lung tissue of mice exposed to CS for 3 months, as compared to corresponding air-exposed mice 4 days after inoculation (Figure 2B).
CS exposure increases the expression of inflammatory cytokines in the upper airways of mice colonized with NTHi
CS exposure does not inhibit the recruitment of inflammatory cells in the upper airways of colonized mice
The phagocytosis activity is reduced in whole blood granulocytes and monocytes
Bacterial colonization is linked with an increased recruitment of immune cells into the lung
We combined a murine model of colonization of the upper respiratory tract with a model of COPD to investigate whether CS-induced inflammation promotes acquisition of bacterial lung pathogens and whether colonizing of the upper airways contributes to increased inflammation in the respiratory tract. We focused on NTHi as this bacterium frequently colonizes lungs of COPD patients and is linked to exacerbations of COPD [2,5] and on S. pneumoniae as colonization of the nasal space by pneumococci occasionally causes pneumonia and invasive disease, especially in subjects exposed to CS or passive smoke [17-19]. Our data show that chronic exposure to CS has an impact on the ability of the host to contain bacterial colonization of the upper airways with bacterial pathogens and that CS-induced colonization is accompanied by increased inflammation of the respiratory tract and susceptibility of the host to pathogens migrating into the lung.
It is hypothesized that exacerbations in COPD are provoked by bacterial strains newly acquired from the environment [2,3]. In line with this hypothesis, our study proves that COPD-like inflammation promotes the acquisition of typical COPD pathogens, such as NTHi, into the upper airways. Increased colonization of the upper airways of CS-exposed mice with NTHi is also associated with an enhanced inflammation in the respiratory tract characterized by an increased release of chemokines and influx of immune cells into the upper airways and into the lung. Thus, our data suggest that CS promotes the acquisition and colonization of the upper airways with respiratory pathogens and that these newly- acquired pathogens contribute to the progression of COPD by enhancing and perpetuating lung inflammation [2,3,8].
For many bacterial pathogens colonization of the upper airways is often a first step in the process leading to infectious diseases [22,23]. Frequent acquisition of bacterial pathogens in the upper airways may also promote infectious lung diseases and invasive diseases in individuals exposed to mainstream or passive smoke. Our data indicate that the increased risk of smokers for community-acquired pneumonia and invasive pneumococcal disease [17-19] and the increased risk of infants exposed to passive smoke of developing infections of the lower respiratory tract  are a direct consequence of CS-induced acquisition of bacterial pathogens into the upper airways. Our results are further in line with findings that children of smoking parents have a significantly higher rate of S. pneumoniae carriage than those of non-smokers .
Several studies have examined how CS affects immune mechanisms at the mucosal surfaces of the respiratory tract [9,27,31-36]. In vitro studies have shown that exposure of respiratory epithelial cells to CS results in the suppression of cellular signaling cascades (e.g. AP-1- and NF-κB-dependent signaling cascades) that are of key importance in the activation of innate immune mechanisms in the case of microbial infections [31,35,36]. Thus, in vitro, CS exposure results in a reduced expression and release of inflammatory mediators and antimicrobial peptides by respiratory epithelial cells infected with bacterial pathogens [9,27,31,35,36]. Moreover, we have previously shown that smokers with community- acquired pneumonia have reduced levels of antimicrobial peptides in their sputum and pharyngeal washings . In this study, we found that chronic CS exposure resulted in reduced expression levels of the antimicrobial peptide mBD-1 in the upper airways of NTHi-colonized mice, even though the colonization levels were increased in CS-exposed mice, as compared to air-exposed mice. It has been shown before that mBD-1 deficient mice are more susceptible to H. influenzae lung infection . Furthermore, it has been shown that CS increases adhesion of bacteria to epithelial cells [37-40]. Grigg et al. showed, for instance, that CS extract stimulates platelet-activating factor receptor- dependent adhesion of S. pneumonaie to respiratory epithelial cells . Thus, the suppression of innate immune functions of respiratory epithelial cells, including the expression of epithelial antimicrobial peptides as well as increased bacterial adherence to epithelial cells, are potential mechanisms responsible for the increased levels of colonization observed in mice chronically exposed to CS.
Studies have also shown that CS impairs the response of immune cells such as alveolar macrophages and neutrophils to bacterial pathogens, which results in a deregulated release of inflammatory mediators and impaired phagocytic activity [41-44]. Alveolar macrophages from ex-smokers with COPD, for instance, showed a reduced expression of inflammatory mediators (e.g. TNF-α) in response to antigens of H. influaenzae, compared to macrophages obtained from ex-smokers without COPD and non-smokers . Moreover, ex vivo studies with alveolar macrophages obtained from CS-exposed mice showed that CS exposure enhances the release of the chemokines IL-1α and MCP-1 and inhibits the release of TNF-α by alveolar macrophages stimulated with NTHi [42,43]. Berenson et al. showed that the phagocytosis of NTHi is impaired in alveolar macrophages obtained from donors with COPD, as compared to that from donors without COPD . Taylor et al. found that monocyte-derived macrophages from COPD patients showed reduced phagocytic responses to H. influenza and S. pneumoniae, compared with smokers and non-smokers, which was not observed by Berenson et al. . Exposure to CS extract also resulted in a reduced uptake of NTHi by murine and human cell line-derived macrophages . Exposure to CS extracts also reduced the complement-mediated phagocytosis of S. pneumoniae by alveolar macrophages ex vivo  and the phagocytosis of E. coli by human neutrophils . In our model, chronic exposure to CS did not result in a defect in the recruitment of phagocytes into the upper airways in response to colonizing bacteria. Chronic CS exposure resulted in increased numbers of neutrophil and macrophages in the upper airways of mice colonized with NTHi and S. pneumoniae, which was associated with increased levels of chemokines in upper airway lavages. However, the phagocytosis activity of whole blood granulocytes and monocytes was inhibited in CS-exposed mice. This was a surprising and not suspected finding which might have impact on extra pulmonal research on tobacco smoke, too. Thus, it is conceivable that impaired phagocytosis of NTHi and S. pneumoniae by neutrophils and macrophages is another potential cause of the increased colonization levels in the upper airways of CS-exposed mice.
In summary, our data indicate that continuous exposure to CS opens a niche for typical COPD pathogens in the upper airways, which results in the acquisition of bacterial pathogens. Our data suggest that bacterial pathogens efficiently colonizing the mucosal surfaces of the upper respiratory tract contribute to increased lung colonization and are a cause of pulmonary inflammation. Frequent acquisition of bacterial pathogens into the upper airways may also promote pneumonia and invasive diseases in individuals exposed to mainstream or passive smoke. Our model system provides a tool for future mechanistic studies to examine mechanisms and potential therapeutic interventions regarding bacterial colonization and COPD exacerbations.
The authors thank Ms Soether for correction of the language. This study was supported by grants from DFG BE 4813/1-1 to CB and Ba 1641/12 to RB.
- Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.View ArticlePubMedPubMed CentralGoogle Scholar
- Sethi S. Infection as a comorbidity of COPD. Eur Respir J. 2010;35:1209–15.View ArticlePubMedGoogle Scholar
- Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl JMed. 2008;359:2355–65.View ArticleGoogle Scholar
- Garmendia J, Morey P, Bengoechea JA. Impact of cigarette smoke exposure on host-bacterial pathogen interactions. Eur Respir J. 2012;39:467–77.View ArticlePubMedGoogle Scholar
- Moghaddam SJ, Ochoa CE, Sethi S, Dickey BF. Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer. Int J Chron Obstruct Pulmon Dis. 2011;6:113–23.View ArticlePubMedPubMed CentralGoogle Scholar
- Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev. 2001;14:336–63.View ArticlePubMedPubMed CentralGoogle Scholar
- Shuto T, Xu H, Wang B, Han J, Kai H, Gu XX, et al. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci USA. 2001;98:8774–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Veeramachaneni SB, Sethi S. Pathogenesis of bacterial exacerbations of COPD. COPD. 2006;3:109–15.View ArticlePubMedGoogle Scholar
- Herr C, Beisswenger C, Hess C, Kandler K, Suttorp N, Welte T, et al. Suppression of pulmonary innate host defence in smokers. Thorax. 2009;64:144–9.View ArticlePubMedGoogle Scholar
- Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res. 2008;57:497–503.View ArticlePubMedGoogle Scholar
- Charlson ES, Chen J, Custers-Allen R, Bittinger K, Li H, Sinha R, et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One. 2010;5:e15216.View ArticlePubMedPubMed CentralGoogle Scholar
- Brook I, Gober AE. Recovery of potential pathogens and interfering bacteria in the nasopharynx of smokers and nonsmokers. Chest. 2005;127:2072–5.View ArticlePubMedGoogle Scholar
- Brook I, Gober AE. Recovery of potential pathogens and interfering bacteria in the nasopharynx of otitis media-prone children and their smoking and nonsmoking parents. Arch Otolaryngol Head Neck Surg. 2005;131:509–12.View ArticlePubMedGoogle Scholar
- Greenberg D, Givon-Lavi N, Broides A, Blancovich I, Peled N, Dagan R. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis. 2006;42:897–903.View ArticlePubMedGoogle Scholar
- Zambon JJ, Grossi SG, Machtei EE, Ho AW, Dunford R, Genco RJ. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol. 1996;67:1050–4.View ArticlePubMedGoogle Scholar
- van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, van der Reijden WA. Smoking affects the subgingival microflora in periodontitis. J Periodontol. 2001;72:666–71.View ArticlePubMedGoogle Scholar
- Almirall J, Bolibar I, Balanzo X, Gonzalez CA. Risk factors for community-acquired pneumonia in adults: a population-based case–control study. Eur Respir J. 1999;13:349–55.View ArticlePubMedGoogle Scholar
- Almirall J, Gonzalez CA, Balanzo X, Bolibar I. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest. 1999;116:375–9.View ArticlePubMedGoogle Scholar
- Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342:681–9.View ArticlePubMedGoogle Scholar
- Jones LL, Hashim A, McKeever T, Cook DG, Britton J, Leonardi-Bee J. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res. 2011;12:5.View ArticlePubMedPubMed CentralGoogle Scholar
- Herr C, Han G, Li D, Tschernig T, Dinh QT, Beisswenger C, et al. Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model. Exp Toxicol Pathol. 2015;67:261–9.View ArticlePubMedGoogle Scholar
- Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun. 2007;75:83–90.View ArticlePubMedGoogle Scholar
- Beisswenger C, Lysenko ES, Weiser JN. Early bacterial colonization induces toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect Immun. 2009;77:2212–20.View ArticlePubMedPubMed CentralGoogle Scholar
- Zola TA, Lysenko ES, Weiser JN. Mucosal clearance of capsule-expressing bacteria requires both TLR and nucleotide-binding oligomerization domain 1 signaling. J Immunol. 2008;181:7909–16.View ArticlePubMedGoogle Scholar
- Li D, Beisswenger C, Herr C, Hellberg J, Han G, Zakharkina T, et al. Myeloid cell RelA/p65 promotes lung cancer proliferation through Wnt/beta-catenin signaling in murine and human tumor cells. Oncogene. 2014;33:1239–48.View ArticlePubMedGoogle Scholar
- Seiler F, Hellberg J, Lepper PM, Kamyschnikow A, Herr C, Bischoff M, et al. FOXO Transcription Factors Regulate Innate Immune Mechanisms in Respiratory Epithelial Cells. J Immunol. 2013;190:1603–13.View ArticlePubMedGoogle Scholar
- Pfeifer P, Voss M, Wonnenberg B, Hellberg J, Seiler F, Lepper PM, et al. IL-17C is a mediator of respiratory epithelial innate immune response. Am J Respir Cell Mol Biol. 2013;48:415–21.View ArticlePubMedGoogle Scholar
- McCool TL, Weiser JN. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun. 2004;72:5807–13.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009;119:1899–909.PubMedPubMed CentralGoogle Scholar
- Moser C, Weiner DJ, Lysenko E, Bals R, Weiser JN, Wilson JM. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun. 2002;70:3068–72.View ArticlePubMedPubMed CentralGoogle Scholar
- Kulkarni R, Rampersaud R, Aguilar JL, Randis TM, Kreindler JL, Ratner AJ. Cigarette smoke inhibits airway epithelial cell innate immune responses to bacteria. Infect Immun. 2010;78:2146–52.View ArticlePubMedPubMed CentralGoogle Scholar
- Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol. 2007;179:6097–106.View ArticlePubMedGoogle Scholar
- Phipps JC, Aronoff DM, Curtis JL, Goel D, O’Brien E, Mancuso P. Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun. 2010;78:1214–20.View ArticlePubMedGoogle Scholar
- Stringer KA, Tobias M, O’Neill HC, Franklin CC. Cigarette smoke extract-induced suppression of caspase-3-like activity impairs human neutrophil phagocytosis. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1572–9.View ArticlePubMedGoogle Scholar
- Manzel LJ, Shi L, O'Shaughnessy PT, Thorne PS, Look DC. Inhibition by cigarette smoke of nuclear factor-kappaB-dependent response to bacteria in the airway. Am J Respir Cell Mol Biol. 2011;44:155–65.View ArticlePubMedGoogle Scholar
- Laan M, Bozinovski S, Anderson GP. Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J Immunol. 2004;173:4164–70.View ArticlePubMedGoogle Scholar
- Fainstein V, Musher DM, Cate TR. Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis. 1980;141:172–6.View ArticlePubMedGoogle Scholar
- El Ahmer OR, Essery SD, Saadi AT, Raza MW, Ogilvie MM, Weir DM, et al. The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells. FEMS Immunol Med Microbiol. 1999;23:27–36.View ArticlePubMedGoogle Scholar
- Grigg J, Walters H, Sohal SS, Wood-Baker R, Reid DW, Xu CB, et al. Cigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cells. Thorax. 2012;67:908–13.View ArticlePubMedGoogle Scholar
- Raman AS, Swinburne AJ, Fedullo AJ. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest. 1983;83:23–7.View ArticlePubMedGoogle Scholar
- Berenson CS, Wrona CT, Grove LJ, Maloney J, Garlipp MA, Wallace PK, et al. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. Am J Respir Crit Care Med. 2006;174:31–40.View ArticlePubMedPubMed CentralGoogle Scholar
- Nikota JK, Shen P, Morissette MC, Fernandes K, Roos A, Chu DK, et al. Cigarette smoke primes the pulmonary environment to IL-1alpha/CXCR-2-Dependent Nontypeable Haemophilus influenzae-Exacerbated Neutrophilia in mice. J Immunol. 2014;193:3134–45.View ArticlePubMedGoogle Scholar
- Gaschler GJ, Skrtic M, Zavitz CC, Lindahl M, Onnervik PO, Murphy TF, et al. Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. Am J Respir Crit Care Med. 2009;179:666–75.View ArticlePubMedGoogle Scholar
- Marti-Lliteras P, Regueiro V, Morey P, Hood DW, Saus C, Sauleda J, et al. Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke. Infect Immun. 2009;77:4232–42.View ArticlePubMedPubMed CentralGoogle Scholar
- Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis. 2006;194:1375–84.View ArticlePubMedGoogle Scholar
- Taylor AE, Finney-Hayward TK, Quint JK, Thomas CM, Tudhope SJ, Wedzicha JA, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J. 2010;35:1039–47.View ArticlePubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.